Portion of Walkway Leading to Eden Garage Bridge Closed July 31-Aug. 2
Due to repair work scheduled to be performed the weekend of July 31-Aug. 2, a portion of the G Level walkway connector leading from the Medical Sciences Building (MSB) and the MSB Service Building/UC Medical Center to the Eden Garage Bridge will be closed and detours will be necessary in some cases.
Work will begin at 6 p.m. Friday, July 31, 8 a.m. Saturday, Aug. 1, and 8 a.m. Sunday, Aug. 2, with eight-hour shifts each day.
The Eden Garage Bridge will remain open during this work. However, the walkway will be closed by the double doors where it enters the MSB Service Building from the MSB receiving building at Level G. Detour signs will be posted directing pedestrians to the G098B Stairs located near the double doors that lead to the MSB. Using the stairs, pedestrians should descend to E Level and then take the E Level ramp to the walkway. Conversely, pedestrians approaching from the Eden Garage Bridge should use the E Level ramp and then return to G Level via the stairs.
Tags
Related Stories
Make Hoxworth Blood Center’s special holiday events part of your family celebrations this December
December 12, 2025
This December, Hoxworth Blood Center, University of Cincinnati, is inviting families across Greater Cincinnati to add something truly meaningful to their holiday traditions: giving the gift of life. With festive community events, beloved local partners and special thank-you gifts for donors, Hoxworth is making it easier, and more heartwarming than ever, to roll up your sleeves and help save lives close to home.
Ohio nurses weigh in on proposed federal loan rule
December 12, 2025
Spectrum News journalist Javari Burnett spoke with UC Dean Alicia Ribar and UC nursing students Megan Romero and Nevaeh Haskins about proposed new federal student loan rules. Romero and Haskins, both seniors, were filmed in the College of Nursing’s Simulation Lab.
New combination treatment improves multiple myeloma outcomes
December 11, 2025
The University of Cincinnati Cancer Center's Ed Faber, DO, provided commentary to Medscape on the COBRA study that found the combination of carfilzomib combined with lenalidomide and dexamethasone (KRd) shows significantly greater efficacy than the previous standard of care.